Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Brain Diseases × elacestrant × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Neoplasms by Site 1 Neoplasms 1 Central Nervous System Neoplasms 1 Central Nervous System Diseases 1 Breast Diseases 1 Brain Neoplasms 1 Brain Diseases 1

Interventions

glutathione pegylated liposomal doxorubicin 1 elacestrant 1 abemaciclib 1 Trastuzumab 1 RAD1901 1 Cancer Vaccines 1 Bevacizumab 1 Adjuvants, Immunologic 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05386108 2026-02-05

ELECTRA

Stemline Therapeutics, Inc.

Phase 1/2 Recruiting

Brain Diseases, Brain Neoplasms, Breast Diseases, Breast Neoplasms, Central Nervous System Diseases, Neoplasms, Neoplasms by Site, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡